Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease

ABSTRACT The survival of any microbe relies on its ability to respond to environmental change. Use of extracytoplasmic function (ECF) RNA polymerase sigma (σ) factors is a major strategy enabling dynamic responses to extracellular signals. Streptomyces species harbor a large number of ECF σ factors,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bohdan Bilyk, Sora Kim, Asif Fazal, Tania A. Baker, Ryan F. Seipke
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/85798e33bd6c4080b4a14e686b45a04f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:85798e33bd6c4080b4a14e686b45a04f
record_format dspace
spelling oai:doaj.org-article:85798e33bd6c4080b4a14e686b45a04f2021-11-15T15:29:16ZRegulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease10.1128/mSphere.00144-202379-5042https://doaj.org/article/85798e33bd6c4080b4a14e686b45a04f2020-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00144-20https://doaj.org/toc/2379-5042ABSTRACT The survival of any microbe relies on its ability to respond to environmental change. Use of extracytoplasmic function (ECF) RNA polymerase sigma (σ) factors is a major strategy enabling dynamic responses to extracellular signals. Streptomyces species harbor a large number of ECF σ factors, nearly all of which are uncharacterized, but those that have been characterized generally regulate genes required for morphological differentiation and/or response to environmental stress, except for σAntA, which regulates starter-unit biosynthesis in the production of antimycin, an anticancer compound. Unlike a canonical ECF σ factor, whose activity is regulated by a cognate anti-σ factor, σAntA is an orphan, raising intriguing questions about how its activity may be controlled. Here, we reconstituted in vitro ClpXP proteolysis of σAntA but not of a variant lacking a C-terminal di-alanine motif. Furthermore, we show that the abundance of σAntA in vivo was enhanced by removal of the ClpXP recognition sequence and that levels of the protein rose when cellular ClpXP protease activity was abolished. These data establish direct proteolysis as an alternative and, thus far, unique control strategy for an ECF RNA polymerase σ factor and expands the paradigmatic understanding of microbial signal transduction regulation. IMPORTANCE Natural products produced by Streptomyces species underpin many industrially and medically important compounds. However, the majority of the ∼30 biosynthetic pathways harbored by an average species are not expressed in the laboratory. This unrevealed biochemical diversity is believed to comprise an untapped resource for natural product drug discovery. Major roadblocks preventing the exploitation of unexpressed biosynthetic pathways are a lack of insight into their regulation and limited technology for activating their expression. Our findings reveal that the abundance of σAntA, which is the cluster-situated regulator of antimycin biosynthesis, is controlled by the ClpXP protease. These data link proteolysis to the regulation of natural product biosynthesis for the first time to our knowledge, and we anticipate that this will emerge as a major strategy by which actinobacteria regulate production of their natural products. Further study of this process will advance understanding of how expression of secondary metabolism is controlled and will aid pursuit of activating unexpressed biosynthetic pathways.Bohdan BilykSora KimAsif FazalTania A. BakerRyan F. SeipkeAmerican Society for MicrobiologyarticleClpXPECF sigma factorsStreptomycesantimycinproteolysisregulation of secondary metabolismMicrobiologyQR1-502ENmSphere, Vol 5, Iss 2 (2020)
institution DOAJ
collection DOAJ
language EN
topic ClpXP
ECF sigma factors
Streptomyces
antimycin
proteolysis
regulation of secondary metabolism
Microbiology
QR1-502
spellingShingle ClpXP
ECF sigma factors
Streptomyces
antimycin
proteolysis
regulation of secondary metabolism
Microbiology
QR1-502
Bohdan Bilyk
Sora Kim
Asif Fazal
Tania A. Baker
Ryan F. Seipke
Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
description ABSTRACT The survival of any microbe relies on its ability to respond to environmental change. Use of extracytoplasmic function (ECF) RNA polymerase sigma (σ) factors is a major strategy enabling dynamic responses to extracellular signals. Streptomyces species harbor a large number of ECF σ factors, nearly all of which are uncharacterized, but those that have been characterized generally regulate genes required for morphological differentiation and/or response to environmental stress, except for σAntA, which regulates starter-unit biosynthesis in the production of antimycin, an anticancer compound. Unlike a canonical ECF σ factor, whose activity is regulated by a cognate anti-σ factor, σAntA is an orphan, raising intriguing questions about how its activity may be controlled. Here, we reconstituted in vitro ClpXP proteolysis of σAntA but not of a variant lacking a C-terminal di-alanine motif. Furthermore, we show that the abundance of σAntA in vivo was enhanced by removal of the ClpXP recognition sequence and that levels of the protein rose when cellular ClpXP protease activity was abolished. These data establish direct proteolysis as an alternative and, thus far, unique control strategy for an ECF RNA polymerase σ factor and expands the paradigmatic understanding of microbial signal transduction regulation. IMPORTANCE Natural products produced by Streptomyces species underpin many industrially and medically important compounds. However, the majority of the ∼30 biosynthetic pathways harbored by an average species are not expressed in the laboratory. This unrevealed biochemical diversity is believed to comprise an untapped resource for natural product drug discovery. Major roadblocks preventing the exploitation of unexpressed biosynthetic pathways are a lack of insight into their regulation and limited technology for activating their expression. Our findings reveal that the abundance of σAntA, which is the cluster-situated regulator of antimycin biosynthesis, is controlled by the ClpXP protease. These data link proteolysis to the regulation of natural product biosynthesis for the first time to our knowledge, and we anticipate that this will emerge as a major strategy by which actinobacteria regulate production of their natural products. Further study of this process will advance understanding of how expression of secondary metabolism is controlled and will aid pursuit of activating unexpressed biosynthetic pathways.
format article
author Bohdan Bilyk
Sora Kim
Asif Fazal
Tania A. Baker
Ryan F. Seipke
author_facet Bohdan Bilyk
Sora Kim
Asif Fazal
Tania A. Baker
Ryan F. Seipke
author_sort Bohdan Bilyk
title Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
title_short Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
title_full Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
title_fullStr Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
title_full_unstemmed Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
title_sort regulation of antimycin biosynthesis is controlled by the clpxp protease
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/85798e33bd6c4080b4a14e686b45a04f
work_keys_str_mv AT bohdanbilyk regulationofantimycinbiosynthesisiscontrolledbytheclpxpprotease
AT sorakim regulationofantimycinbiosynthesisiscontrolledbytheclpxpprotease
AT asiffazal regulationofantimycinbiosynthesisiscontrolledbytheclpxpprotease
AT taniaabaker regulationofantimycinbiosynthesisiscontrolledbytheclpxpprotease
AT ryanfseipke regulationofantimycinbiosynthesisiscontrolledbytheclpxpprotease
_version_ 1718427896032264192